MoneyWorks4Me

Zydus Lifesciences informs about analyst meet

17 Jun 2024 Evaluate
Zydus Lifesciences has informed that the management of the Company will meet group of investors as a part of Jefferies Corporate Access Day at Ahmedabad on Thursday, June 20, 2024.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1140.75 -9.25 (-0.80%)
09-Sep-2026 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.15
Dr. Reddys Labs. 1142.70
Cipla 1376.55
Lupin 2098.70
Zydus Lifesciences 1140.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: